Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND3 pseudogene 4 (MTND3P4) is a **pseudogene**, meaning it represents a non-functional genomic DNA sequence related to the functional MT-ND3 gene. MT-ND3 is a mitochondrial gene encoding a core protein subunit of NADH:ubiquinone oxidoreductase (Complex I) in the electron transport chain, which is involved in mitochondrial energy production[1][2]. However, MTND3P4 does not produce a functional protein, nor does it participate in cellular energy generation or serve as a drug target[3]. Pseudogenes like MTND3P4 may arise from gene duplication or retrotransposition events and often lack coding potential due to mutations or regulatory differences. There is no evidence that MTND3P4 has canonical biological, biochemical, or disease roles; information about function, druggability, biomarkers, or safety does not apply[3]. **Important note:** Information about disease or pharmacology for MT-ND3 (the functional gene) should not be conflated with MT-ND3 pseudogene 4, as only the active MT-ND3 gene is associated with mitochondrial disease and energy metabolism. Pseudogenes generally do not encode proteins and are not considered molecular targets. **Key distinctions:** - MT-ND3 (functional gene) is involved in mitochondrial function and disease; MTND3P4 is a non-coding pseudogene. - MTND3P4 is not a receptor, enzyme, transporter, or any canonical drug target[3]. If you need information about the functional MT-ND3 gene (not the pseudogene), please clarify, as the biological and therapeutic information will be distinct[1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND3 pseudogene 4 (MTND3P4).